Microsoft Unveils Project Quine for AI Powered Biology Research

Project Quine is Microsoft’s new experimental AI research system designed to connect computational biology with physical wet-lab experimentation.

Microsoft Research introduced Project Quine in collaboration with the Broad Institute of MIT and Harvard.

Project Quine connects multiple areas of biology

Quine combines a joint-representation world model with an interactive reasoning system.

The model covers genomics, proteins, chemistry, cell states, and bioimaging, allowing it to work across several biological domains instead of focusing on a single data type.

Microsoft says this cross-modal approach can help researchers uncover relationships that may remain hidden when analyzing biological data separately.

Microsoft sees Quine supporting drug discovery

Microsoft says Quine could help accelerate drug discovery by screening and prioritizing promising candidates computationally before researchers commit limited laboratory resources.

During tests involving pancreatic ductal adenocarcinoma, or PDAC, cell lines, Quine prioritized compounds capable of producing targeted classical-to-basal cellular state shifts over a single weekend.

The system also identified unexpected phenotypic responses during the experiments, giving researchers additional signals to investigate.

The approach could help research teams narrow large candidate sets before moving to more expensive and time-consuming laboratory experiments.

Quine is not intended for clinical use

Microsoft stresses that Project Quine remains a research system and is not intended for clinical use.

Researchers must manually and rigorously evaluate its outputs because the AI can still produce incorrect results.

This means Quine currently acts as a research assistant rather than an autonomous system for making biological or medical decisions.

Researchers can apply for early access

Microsoft has opened applications for its inaugural Quine Fellows program, which will give selected researchers early access to the technology.

The company expects access and commercial capabilities to expand as Quine progresses beyond its current research phase.

Microsoft ultimately plans to bring Quine’s capabilities to products such as Microsoft Discovery.

Elsewhere in AI news, Satya Nadella said the industry has become “way too self-obsessed”, even as Microsoft continues expanding Copilot with Claude Opus 5.5 and GPT-6 Sol across Word, Excel, and other apps. In other AI news, OpenAI has released GPT-6.1 Sol with near-Astra performance.